Mobilicom (NASDAQ: MOB) Is ‘One to Watch’

Greenland Mines (NASDAQ: GRML) (FSE: HK6) Welcomes Trump Comments on Greenland Mineral Exploration and Strategic Importance

TruGolf Holdings (NASDAQ: TRUG) Taps Newly Acquired Polymath to Tokenize Franchise Ownership Records

Versus Systems (NASDAQ: VS) Leadership Highlights Drinkfinger Expansion and AI Approach in Stock2Me Podcast

Wrap Technologies (NASDAQ: WRAP) Expands Beyond a Single Device as Public Safety Moves Toward Integrated Ecosystems

SS Innovations International (NASDAQ: SSII) Submits FDA Response for SSi Mantra Surgical Robotic System

VERAXA Biotech (NASDAQ: VRXA) Presents First In Vivo Proof-of-Concept Data for BiTAC-ADC Platform at World ADC Congress

Regentis Biomaterials (NYSE American: RGNT) Reports Strong Surgeon Interest in GelrinC at International Cartilage Summit

Mobilicom (NASDAQ: MOB) Launches SwarmiX Secure Mesh Communications Solutions for Drone and Robotic Fleets

Regentis Biomaterials (NYSE American: RGNT) to Present at 2026 ThinkEquity Conference on Oct. 15

Greenland Mines (NASDAQ: GRML) Welcomes EU Strategic Project Designation for Neo Performance Materials Silmet 2.0

Versus Systems (NASDAQ: VS) Names Brian Goldenberg CFO to Further Strengthen Financial and Operational Infrastructure

TruGolf Holdings (NASDAQ: TRUG) Completes Acquisition of Polymath Research, Expanding into Institutional Asset Tokenization

Greenland Mines (NASDAQ: GRML) (FSE: HK6) to Participate in Arctic Mining Roundtable at 2026 Arctic Circle Assembly

AZIO AI Holdings (NASDAQ: AZIO) Secures Initial 10 MW Hosting Agreement with Potential $450M Contract Value

How Versus Systems (NASDAQ: VS) Transforms Audience Engagement Through Gamification

BTQ Technologies (NASDAQ: BTQ) (CBOE CA: BTQ) Named Security Partner for MoonPay Korea Stablecoin Infrastructure

SS Innovations International (NASDAQ: SSII) Builds Telerobotic Surgery Position as Remote Procedures Gain Ground

Quantum BioPharma (NASDAQ: QNTM) Enlists Thermo Fisher’s Clinical Research Business to Launch Phase 2 Lucid-MS Trial

VERAXA Biotech (NASDAQ: VRXA) Advances FDA-Aligned Methods to Reduce Animal Testing